Achievements & Recognition

KAT Innovation has demonstrated outstanding early-stage traction through global recognition, successful funding, and clinical progress. Since inception, we've raised over CAD $1 million in non-dilutive grants for R&D, prototyping, and clinical validation. In 2024, we were chosen as one of only 8 startups (from 250) for the prestigious mHUB MedTech Accelerator in Chicago, gaining USD $250,000 equity funding and mentorship. We also secured a spot in the MassChallenge U.S. Early Stage Cohort, selected as 128 from 1,300+ applicants.

These achievements demonstrate our consistent global traction, innovation leadership, and growing confidence from evaluators, investors, and strategic partners across North America, Europe, and Asia.